Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β3 blockade with percutaneous coronary intervention Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Coronary Disease
  • Immunoglobulin Fab Fragments
  • Myocardial Ischemia
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex

abstract

  • Abciximab bolus with infusion given at the time of coronary angioplasty improves outcomes as long as 3 years after the procedure.

publication date

  • August 13, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9256222

Additional Document Info

start page

  • 479

end page

  • 84

volume

  • 278

number

  • 6